Introduction {#section5-1470320316653283}
============

Gestational diabetes mellitus (GDM), characterized as glucose intolerance firstly occurring or recognized during pregnancy, is an important public health problem worldwide.^[@bibr1-1470320316653283],[@bibr2-1470320316653283]^ In China, the incidence increased during 1999--2013, from 2.4% to 12.1%.^[@bibr3-1470320316653283],[@bibr4-1470320316653283]^ Women with GDM possess high risks of adverse pregnancy outcomes and several maternal and perinatal complications, including neonatal hypoglycemia and adiposity, metabolic syndrome and future diabetes mellitus.^[@bibr5-1470320316653283][@bibr6-1470320316653283][@bibr7-1470320316653283][@bibr8-1470320316653283]--[@bibr9-1470320316653283]^ Regarding risk factors for GDM, several environmental triggers have been identified so far, such as obesity, poor diet and physical inactivity.^[@bibr10-1470320316653283][@bibr11-1470320316653283]--[@bibr12-1470320316653283]^ In addition, genetic components have also been reported to contribute to the development of GDM.^[@bibr13-1470320316653283][@bibr14-1470320316653283]--[@bibr15-1470320316653283]^

Adiponectin (*ADIPOQ*) is a protein hormone involved in regulating glucose levels and fatty acid oxidation.^[@bibr16-1470320316653283],[@bibr17-1470320316653283]^ The hormone plays a key role in the metabolic derangements that may lead to type 2 diabetes, atherosclerosis, obesity, metabolic syndrome and insulin resistance.^[@bibr16-1470320316653283],[@bibr18-1470320316653283][@bibr19-1470320316653283]--[@bibr20-1470320316653283]^ The *ADIPOQ* gene, located on chromosome 3q27 in humans, contains three exons. A single nucleotide polymorphism (SNP) in exon 2 of *ADIPOQ* (+45 T/G, rs2241766) may influence the protein expression by affecting RNA splicing and stability.^[@bibr21-1470320316653283]^ The SNP has been shown to be related to type 2 diabetes and insulin resistance.^[@bibr22-1470320316653283][@bibr23-1470320316653283]--[@bibr24-1470320316653283]^

Given the potential role of the *ADIPOQ* +45 T/G polymorphism in diabetes, several association studies have been conducted to assess the association between the polymorphism and risk of GDM.^[@bibr25-1470320316653283][@bibr26-1470320316653283][@bibr27-1470320316653283][@bibr28-1470320316653283][@bibr29-1470320316653283][@bibr30-1470320316653283][@bibr31-1470320316653283]--[@bibr32-1470320316653283]^ The results, however, are inconsistent and inconclusive. For example, Takhshid et al. reported that the TG/GG genotypes had a 2.55-fold increased risk of GDM compared with the TT genotype,^[@bibr31-1470320316653283]^ whereas Beltcheva et al. reported that no association with GDM was found for the polymorphism.^[@bibr25-1470320316653283]^ One reason for the conflicting results is small samples in a single study. Meta-analysis is a useful tool to increase power by pooling all the published data together. In this study, we performed a meta-analysis to clarify whether the *ADIPOQ* +45 T/G polymorphism is associated with the risk of GDM.

Materials and methods {#section6-1470320316653283}
=====================

Records selection {#section7-1470320316653283}
-----------------

PubMed, China National Knowledge Infrastructure, Weipu and Wangfang databases were searched using the following terms: "ADIPOQ or adiponectin" and "polymorphism\* or variant" and "gestational diabetes mellitus" or "Gestational diabetes" (last search update October 30, 2015). Forty-one articles were identified after database searching. We selected publications using the following criteria: (a) studies evaluating the association between *ADIPOQ* +45 T/G polymorphism and the risk of GDM; (b) original genotyping data to compute pooled odds ratios (ORs) and 95% confidence interval (CI); (c) language was not restricted. Among them, 18 articles were removed for duplicate publication. After full-text assessment, 12 articles were excluded for these reasons: no *ADIPOQ* +45 T/G polymorphism (*n* = 8), reviews (*n* = 3), and not a study of GDM (*n* = 1). During data collection, we excluded three articles for repeated data. Finally, eight studies were included in this meta-analysis. A flow diagram of studies selection is presented in [Figure 1](#fig1-1470320316653283){ref-type="fig"}.

![Flow diagram of studies selection.](10.1177_1470320316653283-fig1){#fig1-1470320316653283}

Data extraction {#section8-1470320316653283}
---------------

The following information was extracted by two researchers independently: author, year of publication, country (origin), ethnicity, study design, number of cases and controls, matching criteria, genotyping method, and minor allele frequency in controls. The information was checked by a third researcher to confirm the accuracy.

Statistical analysis {#section9-1470320316653283}
--------------------

The association between the *ADIPOQ* +45 T/G polymorphism and the risk of GDM was evaluated by pooled ORs and their 95% CI under a heterozygote comparison, homozygote comparison, dominant model, recessive model, and allele comparison. A fixed-effects model was used to estimate summary ORs because *p* values for heterogeneity test were ⩽ 0.10 in all comparison analyses.^[@bibr33-1470320316653283]^ To identify the sources of heterogeneity, subgroup analyses were performed based on the Hardy-Weinberg equilibrium (HWE) and sample size (\>100 vs. ⩽100). Logistic meta-regression was also performed according to ethnicity, genotyping methods, HWE, and sample size. Begg's funnel plot was used to test publication bias.^[@bibr34-1470320316653283]^ All analyses were conducted using STATA software (version 10.0, STATA Corporation, College Station, TX, USA).

Results {#section10-1470320316653283}
=======

Characteristics of studies {#section11-1470320316653283}
--------------------------

The characteristics of the included studies are shown in [Table 1](#table1-1470320316653283){ref-type="table"}. In total, eight studies were included in this meta-analysis with 875 cases and 884 controls. Among them, seven studies were of Asian descendants^[@bibr26-1470320316653283][@bibr27-1470320316653283][@bibr28-1470320316653283][@bibr29-1470320316653283][@bibr30-1470320316653283][@bibr31-1470320316653283]--[@bibr32-1470320316653283]^ and one study was of European descendants.^[@bibr25-1470320316653283]^ The sample sizes were relatively small in all the studies, with the least having 79 participants^[@bibr30-1470320316653283]^ and the most having 436 participants.^[@bibr28-1470320316653283]^ Most of the studies (62.5%) reported a matched frequency of controls to cases.^[@bibr25-1470320316653283],[@bibr27-1470320316653283],[@bibr29-1470320316653283],[@bibr31-1470320316653283],[@bibr32-1470320316653283]^ Several genotyping methods were used, including TaqMan, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and DNA sequencing. However, only two studies reported quality control to ensure the reproducibility of the genotyping assay.^[@bibr25-1470320316653283],[@bibr31-1470320316653283]^ Most of the studies (75.0%) were consistent with HWE except for one study departing from HWE^[@bibr27-1470320316653283]^ and one study without available data to assess HWE.^[@bibr25-1470320316653283]^ Minor allele frequency in controls varied greatly, ranging from 0.10 to 0.49.

###### 

Characteristics of studies included in this meta-analysis.

![](10.1177_1470320316653283-table1)

  First author^reference^                 Year of publication   Country (region)      Ethnicity   Study design    Number of cases   Controls   Matching criteria               Genotyping method   MAF in controls
  --------------------------------------- --------------------- --------------------- ----------- --------------- ----------------- ---------- ------------------------------- ------------------- -----------------
  Beltcheva^[@bibr25-1470320316653283]^   2014                  Bulgaria (Sofia)      European    Case-control    130               130        Age and degree of obesity       TaqMan              0.10
  Han^[@bibr26-1470320316653283]^         2015                  China (Nantong)       Asian       Cross-section   128               140        --                              PCR-RFLP            0.26
  Hua^[@bibr27-1470320316653283]^         2014                  China (Wuxi)          Asian       Case-control    112               150        Age and gestational week        PCR-RFLP            0.49
  Li^[@bibr28-1470320316653283]^          2013                  China (Beijing)       Asian       Case-control    264               172        --                              Sequencing          0.24
  Liu^[@bibr29-1470320316653283]^         2006                  China (Wuxi)          Asian       Case-control    52                34         Age and gestational week        PCR-RFLP            0.47
  Low^[@bibr30-1470320316653283]^         2011                  Malaysia (Selangor)   Asian       Case-control    26                53         --                              PCR-RFLP            0.18
  Takhshid^[@bibr31-1470320316653283]^    2015                  Iran (Shiraz)         Asian       Case-control    65                70         Age                             PCR-RFLP            0.11
  Zhang^[@bibr32-1470320316653283]^       2014                  China (Nanning)       Asian       Case-control    98                135        Age, BMI and gestational week   PCR-RFLP            0.27

MAF: minor allele frequency; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; BMI: body mass index.

Meta-analysis {#section12-1470320316653283}
-------------

As shown in [Table 2](#table2-1470320316653283){ref-type="table"}, no significant association was observed between the *ADIPOQ* +45 T/G polymorphism and the risk of GDM (heterozygote comparison: OR = 1.15, 95% CI, 0.70--1.89; homozygote comparison: OR = 1.21, 95% CI, 0.48--3.03; dominant model: OR = 0.86, 95% CI, 0.50--1.48, recessive model: OR = 1.21, 95% CI, 0.62--2.33, and allele comparison: OR = 1.17, 95% CI, 0.79--1.76, respectively) ([Figure 2](#fig2-1470320316653283){ref-type="fig"}). After excluding two studies with Hardy-Weinberg disequilibrium, no significant association was found. Additionally, we performed subgroup analysis according to sample size (\> 100 and ⩽100); negative results were also observed in both subgroups.

###### 

Meta-analysis of the *ADIPOQ* +45 T/G polymorphism with the risk of gestational diabetes mellitus.

![](10.1177_1470320316653283-table2)

                *n*   Cases/controls   TG vs. TT           GG vs. TT   Dominant             Recessive   G vs. T                                                                       
  ------------- ----- ---------------- ------------------- ----------- -------------------- ----------- -------------------- --------- ------------------- ------ ------------------- ---------
  Total         8     875/884          1.15 (0.70--1.89)   \<0.001     1.21 (0.48--3.03)    \<0.001     0.86 (0.50--1.48)    \<0.001   1.21 (0.62--2.33)   0.01   1.17 (0.79--1.76)   \<0.001
  HWE           6     763/734          1.35 (0.84--2.17)   0.006       1.54 (0.56--4.11)    0.004       0.72 (0.43--1.19)    0.001     1.49 (0.77v2.88)    0.10   1.33 (0.93--1.90)   0.001
  Sample size                                                                                                                                                                         
  \>100         6     797/797          1.29 (0.83--2.01)   0.01        1.46 (0.55--3.83)    0.001       0.76 (0.45--1.28)    \<0.001   1.34 (0.64v2.82)    0.01   1.27 (0.86--1.89)   \<0.001
  ⩽100          2     78/87            0.73 (0.07--7.88)   0.001       0.93 (0.03--29.22)   0.01        1.35 (0.11--16.57)   \<0.001   1.05 (0.12--9.44)   0.09   0.88 (0.15--5.26)   \<0.001

ADIPOQ: adiponectin; OR: odds ratio; CI: confidence interval; HWE: Hardy-Weinberg equilibrium.

Random-effects model was used.

*P* value for heterogeneity test.

![Meta-analysis of the *ADIPOQ* +45 T/G polymorphism with the risk of gestational diabetes mellitus (G vs. T). The random-effects model was used.](10.1177_1470320316653283-fig2){#fig2-1470320316653283}

### Heterogeneity analysis and publication bias {#section13-1470320316653283}

In overall and subgroup analyses, we detected apparent heterogeneity (*p* ⩽ 0.10). Logistic meta-regression was used to explore the sources of heterogeneity. We took the common variables influencing heterogeneity into consideration: ethnicity, genotyping methods, HWE, and sample size. However, none of these factors affected the heterogeneity among studies.

Begg's funnel plot was used to test publication bias, and no evidence of publication bias was found (*p* \> 0.05) in the meta-analysis ([Figure 3](#fig3-1470320316653283){ref-type="fig"}).

![Begg's funnel plot for testing publication bias. Each circle indicates a separate study. (a) TG vs. TT; (b) GG vs. TT; (c) dominant model; (d) recessive model. OR: odds ratio.](10.1177_1470320316653283-fig3){#fig3-1470320316653283}

Discussion {#section14-1470320316653283}
==========

To the best of our knowledge, this is the first meta-analysis to investigate the relationship of the *ADIPOQ* +45 T/G polymorphism with GDM. We failed to find any association between the SNP and the risk of GDM, suggesting that the *ADIPOQ* +45 T/G polymorphism may not be a risk factor for the etiology of GDM.

Previously, several SNPs have been performed to evaluate the association with GDM, such as rs2241766 (Gly15Gly, +45 T/G) in exon 2, rs266729 (−11377 C/G) and rs17300539 (−11391G/A) in the promoter region, and rs1501299 (+276 G/T) in intron 2.^[@bibr25-1470320316653283][@bibr26-1470320316653283][@bibr27-1470320316653283][@bibr28-1470320316653283][@bibr29-1470320316653283][@bibr30-1470320316653283][@bibr31-1470320316653283]--[@bibr32-1470320316653283]^ Among them, the *ADIPOQ* +45 T/G polymorphism is the most frequently investigated. Controversial results, however, have been obtained. In this study, we collected all previous publications and performed a meta-analysis to assess the association of the *ADIPOQ* +45 T/G polymorphism with the risk of GDM. Our meta-analysis provided evidence that the polymorphism was not a risk factor for the development of GDM although 75% (six of eight) studies reported a positive result.^[@bibr26-1470320316653283],[@bibr27-1470320316653283],[@bibr29-1470320316653283][@bibr30-1470320316653283][@bibr31-1470320316653283]--[@bibr32-1470320316653283]^ After subgroup analysis according to HWE and sample size, null results were also observed.

Obvious heterogeneity was detected among studies. We used logistic meta-regression to examine the sources of heterogeneity based on ethnicity, genotyping methods, HWE, and sample size. None of these parameters could explain the heterogeneity, indicating that other unknown reasons may influence the heterogeneity. As most of the studies previously reported a significant association between the *ADIPOQ* +45 T/G polymorphism and susceptibility for GDM, in this meta-analysis we used Begg's funnel plot to test if there is a tendency of prior publication positive results. However, no evidence of publication bias was found.

These are some limitations in this study. Firstly, sample size is very small in each single study as well as in this meta-analysis, which may result in false-negative result due to insufficient power. Secondly, very limited data in the literature reported the association between the *ADIPOQ* +45 T/G polymorphism and serum adiponectin level, which prevented further genotype-phenotype analysis. Thirdly, nearly all the studies included in this meta-analysis were of Asian descendants, and thus the results cannot be directly extended to other ethnicities. Further evaluation is warranted, especially in multi-ethnic populations.

In conclusion, this meta-analysis provides evidence that the *ADIPOQ* +45 T/G polymorphism was not related to the risk of GDM. Further multicenter, prospective studies with larger sample size would be of great value to confirm the result. Additionally, gene-gene and genotype-phenotype analysis may help to comprehensively understand the role of the SNP in the etiology of GDM.
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